USANA HEALTH SCIENCES, INC. Notes Reduction
USANA HEALTH SCIENCES, INC. (USNA) reported Notes Reduction of $86.00 thousand for the 12-month period ending 2017-12-30, per its 10-K filed 2020-02-25.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesReduction · last filed 2020-02-25
- USANA HEALTH SCIENCES, INC. notes reduction for the quarter ending 2017-12-30 was -$326.00K, a 323.29% decline year-over-year.
- USANA HEALTH SCIENCES, INC. notes reduction for the quarter ending 2017-09-30 was $221.00K, a 23.79% decline year-over-year.
- USANA HEALTH SCIENCES, INC. notes reduction for the quarter ending 2017-07-01 was $0.00, a 100.00% decline year-over-year.
- USANA HEALTH SCIENCES, INC. notes reduction for the quarter ending 2017-04-01 was $191.00K, a 62.18% decline year-over-year.
- USANA HEALTH SCIENCES, INC. notes reduction for fiscal 2017 was $86.00K, a 93.32% decline from fiscal 2016.
- USANA HEALTH SCIENCES, INC. notes reduction for fiscal 2016 was $1.29M, a 33.33% increase from fiscal 2016.
- USANA HEALTH SCIENCES, INC. notes reduction for fiscal 2016 was $966.00K, a 34.17% increase from fiscal 2015.
- USANA HEALTH SCIENCES, INC. notes reduction for fiscal 2015 was $720.00K, a 263.64% increase from fiscal 2013.
| Period end | Notes Reduction 3 month | Notes Reduction 6 month | Notes Reduction 9 month | Notes Reduction 12 month |
|---|---|---|---|---|
| 2017-12-30 | -$326.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$105.00K derived: sum of 2 quarters · filed 2020-02-25 | -$105.00K derived: sum of 3 quarters · filed 2020-02-25 | $86.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $221.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $221.00K derived: sum of 2 quarters · filed 2018-11-07 | $412.00K 10-Q · filed 2018-11-07 | $558.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-07-01 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $191.00K 10-Q · filed 2018-08-08 | $337.00K derived: sum of 3 quarters · filed 2019-02-26 | $627.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-04-01 | $191.00K 10-Q · filed 2018-05-09 | $337.00K derived: sum of 2 quarters · filed 2019-02-26 | $627.00K derived: sum of 3 quarters · filed 2019-02-26 | $974.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $436.00K derived: sum of 2 quarters · filed 2019-02-26 | $783.00K derived: sum of 3 quarters · filed 2019-02-26 | $1.29M 10-K · filed 2019-02-26 |
| 2016-10-01 | $290.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $637.00K derived: sum of 2 quarters · filed 2017-11-08 | $1.14M 10-Q · filed 2017-11-08 | $1.64M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-07-02 | $347.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $852.00K 10-Q · filed 2017-08-09 | $1.35M derived: sum of 3 quarters · filed 2018-02-28 | $1.76M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-04-02 | $505.00K 10-Q · filed 2017-05-10 | $1.00M derived: sum of 2 quarters · filed 2018-02-28 | $1.42M derived: sum of 3 quarters · filed 2018-02-28 | $1.42M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-01-02 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $910.00K derived: sum of 2 quarters · filed 2018-02-28 | $911.00K derived: sum of 3 quarters · filed 2018-02-28 | $966.00K 10-K · filed 2018-02-28 |
| 2015-10-03 | $410.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $411.00K derived: sum of 2 quarters · filed 2016-11-09 | $466.00K 10-Q · filed 2016-11-09 | $586.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-07-04 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $56.00K 10-Q · filed 2016-08-09 | $176.00K derived: sum of 3 quarters · filed 2017-03-01 | $660.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-04-04 | $55.00K 10-Q · filed 2016-05-11 | $175.00K derived: sum of 2 quarters · filed 2017-03-01 | $659.00K derived: sum of 3 quarters · filed 2017-03-01 | $713.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-01-03 | $120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $604.00K derived: sum of 2 quarters · filed 2017-03-01 | $658.00K derived: sum of 3 quarters · filed 2017-03-01 | $720.00K 10-K · filed 2017-03-01 |
| 2014-09-27 | $484.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $538.00K derived: sum of 2 quarters · filed 2015-11-12 | $600.00K 10-Q · filed 2015-11-12 | |
| 2014-06-28 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $116.00K 10-Q · filed 2015-08-12 | ||
| 2014-03-29 | $62.00K 10-Q · filed 2015-05-13 | |||
| 2013-12-28 | $198.00K 10-K · filed 2016-03-01 | |||
| 2013-06-29 | $6.00K 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |